Evidence of platelet activation in multiple sclerosis

William A Sheremata1, Wenche Jy, Lawrence L Horstman

  • 1Multiple Sclerosis Center and Department of Neurology Miller School of Medicine, University of Miami, Miami, Florida, USA. sheremaw@bellsouth.net

Abstract

Insights

Platelets show significant activation in multiple sclerosis (MS) patients, indicated by elevated markers. Further research is needed to understand the causes and implications of this platelet activation in MS.

Area of Science:

  • Neurology
  • Hematology
  • Immunology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Previous studies suggested platelet activation in treatment-naive MS patients.
  • Severe bleeding events prompted investigation into platelet function abnormalities in MS.

Purpose of the Study:

  • To investigate platelet activation and function in stable, untreated multiple sclerosis (MS) patients.
  • To compare platelet activation markers in MS patients versus healthy controls.

Main Methods:

  • Studied 33 stable, untreated MS patients and 92 healthy controls.
  • Measured platelet counts, plasma platelet microparticles (PMP), P-selectin expression (CD62p), circulating platelet microaggregates (PAg), and platelet-associated IgG/IgM.
  • Assessed plasma protein S activity.

Main Results:

  • MS patients exhibited significantly elevated PMP (p < 0.001) and CD62p expression (p < 0.001) compared to controls, indicating increased platelet activation.
  • Platelet-associated IgM was marginally elevated in MS patients (p = 0.01), but IgG levels did not differ significantly.
  • Plasma protein S activity showed no significant difference between MS patients and controls.

Conclusions:

  • Platelets are demonstrably activated in multiple sclerosis patients.
  • The underlying mechanisms and clinical significance of platelet activation in MS remain undetermined.
  • Further investigation into platelet activation and function in MS is warranted.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...